QuickView for GDC0879 (compound)

1. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

1. Validation and application of a liquid chromatography-tandem mass spectrometric method for the deter…
2. Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species.
3. A novel cell-based assay for the high-throughput screening of epithelial-mesenchymal transition inhi…
4. Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status a…
5. Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.

There were no clinical trials for GDC0879